^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             37    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13031004 13581001    
                           13581010 13581014 13991002    
                           13991004 13991007 13991009    
                           13991010 16591001 16591003    
                           16591006 17601002 17601003    
                           17601005 17601007 17601012    
                           17601014 17601025 17661002    
                           17661004 17661006 19691001    
                           19731001 19731004 19731006    
                           19831001 19831005 19831008    
                           19901003                      
      AVISITN         4    1 4 8 12                      
      trtn            3    1 2 3                         
      SSNRISN         2    1 2                           
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      wk12            2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     38
              Columns in Z                      0
              Subjects                         37
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read             121
          Number of Observations Used             121
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       347.36618660                
          1              2       313.33070880      0.01908057
          2              1       312.03949879      0.00230470
          3              1       311.89730126      0.00005120
          4              1       311.89434679      0.00000004
          5              1       311.89434448      0.00000000


                   Convergence criteria met.                    
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.8838
                UN(2,1)     id           0.2258
                UN(2,2)     id           0.9913
                UN(3,1)     id           0.2404
                UN(3,2)     id           0.6372
                UN(3,3)     id           1.3347
                UN(4,1)     id           0.3806
                UN(4,2)     id           0.8676
                UN(4,3)     id           1.1182
                UN(4,4)     id           1.7400


                        Fit Statistics

             -2 Res Log Likelihood           311.9
             AIC (Smaller is Better)         331.9
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             AICC (Smaller is Better)        334.2
             BIC (Smaller is Better)         348.0


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         35.47          <.0001


                 Type 3 Tests of Fixed Effects
 
                           Num     Den
     Effect                 DF      DF    F Value    Pr > F

     BASE                    1    32.3       9.58    0.0040
     trtn                    2    33.4       0.76    0.4753
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                           Num     Den
     Effect                 DF      DF    F Value    Pr > F

     wk12                    1    19.2       1.85    0.1899
     SSNRISN                 1    33.4       1.43    0.2398
     BASE*wk12               1    18.9       2.44    0.1349
     trtn*SSNRISN            2    31.5       0.36    0.6999
     trtn*wk12               2      19       0.67    0.5245
     SSNRISN*wk12            1      20       3.14    0.0916
     trtn*SSNRISN*wk12       1    19.2       0.25    0.6237


 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                       Concomitant
                       Use of
                       SSRI/SNRI                Standard
 Effect         trtn   (N)           Estimate      Error     DF

 trtn*SSNRISN   1      1              -0.7940     0.7756   32.6
 trtn*SSNRISN   1      2              -1.3721     0.3876   28.3
 trtn*SSNRISN   2      1              -0.9056     0.6949   26.6
 trtn*SSNRISN   2      2              -1.2387     0.3005   32.1
 trtn*SSNRISN   3      1              Non-est                  
 trtn*SSNRISN   3      2              -0.9907     0.3152   31.6

 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                      Concomitant
                      Use of
                      SSRI/SNRI
Effect         trtn   (N)           t Value   Pr > |t|    Alpha

trtn*SSNRISN   1      1               -1.02     0.3135     0.05
trtn*SSNRISN   1      2               -3.54     0.0014     0.05
trtn*SSNRISN   2      1               -1.30     0.2037     0.05
trtn*SSNRISN   2      2               -4.12     0.0002     0.05
trtn*SSNRISN   3      1                                        
trtn*SSNRISN   3      2               -3.14     0.0036     0.05

 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                          Concomitant
                          Use of
                          SSRI/SNRI
    Effect         trtn   (N)              Lower       Upper

    trtn*SSNRISN   1      1              -2.3727      0.7847
    trtn*SSNRISN   1      2              -2.1658     -0.5785
    trtn*SSNRISN   2      1              -2.3324      0.5212
    trtn*SSNRISN   2      2              -1.8507     -0.6267
    trtn*SSNRISN   3      1                                 
    trtn*SSNRISN   3      2              -1.6331     -0.3483
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             22    10631001 10631002 10631003    
                           11601002 11601006 11601007    
                           13031001 13581001 13581010    
                           13581014 13991002 13991004    
                           13991007 13991009 16591001    
                           17601005 17601007 17601014    
                           17661004 19731006 19831001    
                           19901003                      
      AVISITN         4    1 4 8 12                      


                          Dimensions

              Covariance Parameters            10
              Columns in X                     10
              Columns in Z                      0
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Subjects                         22
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              72
          Number of Observations Used              72
          Number of Observations Not Used           0


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       210.27687297                
          1              2       186.15226640      0.01079248
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          2              1       185.70976682      0.00115521
          3              1       185.66591834      0.00002489
          4              1       185.66503475      0.00000002
          5              1       185.66503422      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           1.2665
                UN(2,1)     id           0.3136
                UN(2,2)     id           0.8902
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,1)     id           0.3188
                UN(3,2)     id           0.7686
                UN(3,3)     id           1.6473
                UN(4,1)     id           0.2374
                UN(4,2)     id           0.9233
                UN(4,3)     id           1.1361
                UN(4,4)     id           1.5822


                        Fit Statistics

             -2 Res Log Likelihood           185.7
             AIC (Smaller is Better)         205.7
             AICC (Smaller is Better)        209.9
             BIC (Smaller is Better)         216.6
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         24.61          0.0034


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    BASE                      1    18.6       6.65    0.0186
    trtn1                     1      18       0.03    0.8584
    wk12                      1      11       2.91    0.1158
    SSNRISN1                  1    16.3       0.95    0.3429
    BASE*wk12                 1      11       3.48    0.0890
    trtn1*SSNRISN1            1    16.2       0.64    0.4367
    trtn1*wk12                1      11       2.92    0.1154
    wk12*SSNRISN1             0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    trtn1*wk12*SSNRISN1       0                             


                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO  Week 4    -1.1668    1.3194  16.6    -0.88    0.3891
2 ACT-PBO  Week 4   -0.08419    0.4652    18    -0.18    0.8584
1 ACT-PBO  Week 12   Non-est                                   
2 ACT-PBO  Week 12   -0.9889    0.7127  15.7    -1.39    0.1847

 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
       Label                Alpha       Lower       Upper

       1 ACT-PBO  Week 4     0.05     -3.9554      1.6219
       2 ACT-PBO  Week 4     0.05     -1.0616      0.8932
       1 ACT-PBO  Week 12                                
       2 ACT-PBO  Week 12    0.05     -2.5023      0.5245


                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction       1   16.2      0.64
 Treatment*Week 12*Subgroup Interaction                        

 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction    0.4367
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class      Levels    Values

      id             28    10631001 10631003 11601002    
                           11601006 13031001 13031004    
                           13581001 13581010 13581014    
                           13991010 16591003 16591006    
                           17601002 17601003 17601007    
                           17601012 17601025 17661002    
                           17661004 17661006 19691001    
                           19731001 19731004 19731006    
                           19831001 19831005 19831008    
                           19901003                      
      AVISITN         4    1 4 8 12                      


 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     10
              Columns in Z                      0
              Subjects                         28
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              88
          Number of Observations Used              88
          Number of Observations Not Used           0


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       258.96712139                
          1              2       231.24084775      0.06512085
          2              1       227.79086234      0.01669977
          3              1       226.98078571      0.00199508
          4              1       226.89163309      0.00005344
          5              1       226.88940201      0.00000006
          6              1       226.88939942      0.00000000


                   Convergence criteria met.                    


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.5484
                UN(2,1)     id           0.2552
                UN(2,2)     id           1.3967
                UN(3,1)     id           0.3075
                UN(3,2)     id           1.0652
                UN(3,3)     id           1.8930
                UN(4,1)     id           0.2712
                UN(4,2)     id           1.3180
                UN(4,3)     id           1.6596
                UN(4,4)     id           2.3184


                        Fit Statistics

             -2 Res Log Likelihood           226.9
             AIC (Smaller is Better)         246.9
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             AICC (Smaller is Better)        250.1
             BIC (Smaller is Better)         260.2


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         32.08          0.0002


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    BASE                      1    23.7       4.90    0.0368
    trtn2                     1    23.7       0.03    0.8647
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
    Effect                   DF      DF    F Value    Pr > F

    wk12                      1    13.7       0.19    0.6703
    SSNRISN1                  1    22.9       1.32    0.2631
    BASE*wk12                 1    13.7       0.38    0.5479
    trtn2*SSNRISN1            1      23       1.44    0.2421
    trtn2*wk12                1    13.3       1.79    0.2037
    wk12*SSNRISN1             0                             
    trtn2*wk12*SSNRISN1       0                             


 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO    Week 4   -1.2540    1.0487    23    -1.20    0.2440
2 ACT-PBO  Week 4     0.05328    0.3092  23.7     0.17    0.8647
1 ACT-PBO  Week 12    Non-est                                   
2 ACT-PBO  Week 12    -0.6343    0.6022  18.6    -1.05    0.3056

                           Estimates
 
      Label                 Alpha       Lower       Upper

      1 ACT-PBO    Week 4    0.05     -3.4235      0.9155
      2 ACT-PBO  Week 4      0.05     -0.5854      0.6919
      1 ACT-PBO  Week 12                                 
      2 ACT-PBO  Week 12     0.05     -1.8965      0.6278
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction       1     23      1.44
 Treatment*Week 12*Subgroup Interaction                        

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction    0.2421
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
